TY  - GEN
AU  - Deshpande,Vrushali
AU  - Krishnan,Rameshkumar
AU  - Philip,Sheena
AU  - Faludi,Ildiko
AU  - Ponnusamy,Thiruvelselvan
AU  - Thota,Lakshmi Narasimha Rao
AU  - Endresz,Valeria
AU  - Lu,Xinjie
AU  - Kakkar,Vijay V
AU  - Mundkur,Lakshmi A
TI  - Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice
SN  - 1755-5922
PY  - 2017///0217
KW  - Administration, Oral
KW  - Animals
KW  - Antigens
KW  - administration & dosage
KW  - Aortic Diseases
KW  - genetics
KW  - Apolipoproteins E
KW  - deficiency
KW  - Atherosclerosis
KW  - CTLA-4 Antigen
KW  - immunology
KW  - Disease Models, Animal
KW  - Female
KW  - Forkhead Transcription Factors
KW  - Genetic Predisposition to Disease
KW  - Genetic Vectors
KW  - Immune Tolerance
KW  - Immunization
KW  - Immunotherapy
KW  - methods
KW  - Inflammation Mediators
KW  - Interleukin-10
KW  - Lipid Metabolism
KW  - Macrophages
KW  - Male
KW  - Mice, Inbred C57BL
KW  - Mice, Knockout
KW  - Mycobacterium smegmatis
KW  - Oligopeptides
KW  - Phenotype
KW  - T-Lymphocytes, Regulatory
KW  - Time Factors
KW  - Transforming Growth Factor beta
KW  - Vaccines, Synthetic
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1111/1755-5922.12201
ER  -